Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Combined antibiotics" patented technology

Amoxicillin (Amoxil®, Moxatag™) is a prescription antibiotic approved to treat a variety of different infections. Although it is often used by itself, amoxicillin can also be combined with other antibiotics to treat certain infections.

Medicament for treating proventriculitis of poultry and preparation method thereof

The invention relates to the technical field of poultry medicines, and particularly discloses a medicament for treating poultry proventriculitis and a preparation method thereof, the medicament comprises the following raw materials by weight: 8-20 parts of a compound antibiotic, 2-5 parts of a slow-release antibacterial drug, 60-70 parts of sodium chloride, 10-16 parts of magnesium sulfate and 5-10 parts of a modified corn starch premix. According to the medicament for treating the proventriculitis of the poultry, disclosed by the invention, the effective medicament can play a stable and efficient drug effect at the proventriculitis of the poultry, the formula is reasonable, and the treatment effect is exact.
Owner:RUGAO LONGJUN VETERINARY DRUG CO LTD

A composition for preventing or treating periodontal disease and a dental composite antibiotic ointment composition

PendingCN122295112ADiseaseDental composite
The present invention relates to a composition for preventing or treating periodontal disease and a dental composite antibiotic ointment composition. The composition for preventing or treating periodontal disease according to the present invention comprises minocycline and metronidazole as effective ingredients.
Owner:MX BIO CO LTD

Lactobacillus johnsonii for modulating the endocannabinoid system in the colon and uses thereof

This invention discloses a strain of *Lactobacillus johnsonii* that regulates the colonic endocannabinoid system and its applications, belonging to the field of microbial technology. This invention is the first to discover and verify that *Lactobacillus johnsonii* strain LJEH8 can significantly promote the expression of DGLβ in colonic epithelial cells and colonic tissue, thereby effectively regulating the colonic endocannabinoid system. This strain provides a new potential target and microbial resource for the prevention and intervention of intestinal diseases, and has good application prospects. Animal experiments show that in a model of intestinal flora disorder induced by combined antibiotic treatment, colonization of *Lactobacillus johnsonii* LJEH8 can significantly restore colonic DGLβ protein levels, confirming its stable and effective regulatory function in vivo.
Owner:SOUTHWEST UNIV